Bioassay guided fractionation, isolation and characterization of hepatotherapeutic 1, 3-di-ortho-galloyl quinic acid from the methanol extract of the leaves of Pterocarpus santalinoides

Leaf extracts of Pterocarpus santalinoides DC are traditionally used to ameliorate ageing-related ailments such as heart and liver diseases, and have been reported to be protective against toxic injuries to the liver. This study aimed to isolate and characterize the hepatoprotective/hepatotherapeuti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of ethnopharmacology 2023-01, Vol.301, p.115864, Article 115864
Hauptverfasser: Ihedioha, Thelma E., Asuzu, Isaac U., Anaga, Aruh O., Ihedioha, John I., Nnadi, Charles O.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Leaf extracts of Pterocarpus santalinoides DC are traditionally used to ameliorate ageing-related ailments such as heart and liver diseases, and have been reported to be protective against toxic injuries to the liver. This study aimed to isolate and characterize the hepatoprotective/hepatotherapeutic principle in the methanol leaf extract of P. santalinoides. Fresh leaves of P. santalinoides were dried under shade and ground into powder. The ground leaves (2 Kg) were extracted with 80% methanol by maceration. Fractionation was carried out using column and thin layer chromatography techniques. Bioassay of fractions and sub-fractions was done using carbon tetrachloride (CCl4)-induced hepatotoxicity model in albino rats. Phytochemical analysis was carried out on the active compound. Characterization and structural elucidation of the active compound using high performance liquid chromatography and nuclear magnetic resonance spectroscopy was done. Extraction yielded 260 g dry extract. Six fractions (F1, F2, F3, F4, F5 and F6) were obtained after column and thin layer chromatography, with F6 (Rf = 0.78; Yield = 2.13 g) being the most active hepatotherapeutic fraction that significantly (p 
ISSN:0378-8741
1872-7573
DOI:10.1016/j.jep.2022.115864